Genotide Biosciences Inc.

At Genotide, we are committed to providing products and services for peptide, genomics and proteomics research at a highly cost-efficient manner without compromising quality. We also provide raw materials for peptide synthesis, including resins and other relevant reagents.

Contact Details: P.O. Box 1026, Lawrence, KS Lawrence KS 66044 United States of America Tel: (785) 749-1177 Fax: (785) 727-4424 Email: sales@genotide.com WWW: www.genotide.com

Loading...

BioNews Results for Genotide Biosciences Inc.:
Sangamo BioSciences Provides Update on Phase 1 Safety Trial of SB-728-T for HIV/AIDS	PR Newswire:  Nov 23 2009 12:47AM Matching: biosciences inc
Hungarian Cancer Formula Producer Questions U.S. Introduction of AveUltra	PR Newswire:  Nov 23 2009 12:41AM Matching: biosciences inc
Ym Biosciences Announces Nimotuzumab Results In Advanced Triple-negative Breast Cancer Model Presented At Aacr	PR Newswire:  Nov 23 2009 12:47AM Matching: biosciences inc
Ym Biosciences Reports Cyt997 Oral Vascular Disrupting Agent Results Presented At Aacr-nci-eortc Meeting	PR Newswire:  Nov 23 2009 12:38AM Matching: biosciences inc
Arcadia Biosciences and Vilmorin Announce Strategic Alliance to Develop and Market Nitrogen Use Efficient Whea	World Energy Source:  Nov 22 2009 9:24AM Matching: biosciences inc
Promote your company here: BioNewsCast - Press Release Distribution	→View more Genotide Biosciences Inc. news.

Contact BioPortfolio for a quote for a customised Excel verision of BioCorporate or BioEmail databases.

This page has been viewed 220 times since April 2007, the link to the organisation's website has been followed 34 times

Search for more companies in Lawrence

Search for more companies in KS

This site uses Thumbshots previews, resources from the NCBI applied. Maps are centred on zip/postcodes and should not be relied upon for exact building locations. Some information on this page has been collected automatically and may not have been verified.
BioPortfolio search results for Genotide Biosciences Inc.